Last reviewed · How we verify
NCT06411951: INTUK
Integrated Care After Repeated Psychiatric Hospital Stays - Evaluation of an Interdisciplinary Treatment Program
trial testing Participation in the INTUK care offer at Klinik Zugersee in High Utilization / Heavy Use in 90 participants. Enrolling by invitation.
31 May 2027
Quick facts
| Lead sponsor | Michael Rufer |
|---|---|
| Status | ENROLLING BY INVITATION |
| Study type | OBSERVATIONAL |
| Enrollment | 90 |
| Start date | 1 June 2023 |
| Primary completion | 31 May 2027 |
| Estimated completion | 31 December 2027 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Participation in the INTUK care offer at Klinik Zugersee
Conditions studied
- High Utilization / Heavy Use — all drugs for High Utilization / Heavy Use →
- Psychiatric Hospitalization — all drugs for Psychiatric Hospitalization →
- Rehospitalization — all drugs for Rehospitalization →
- Intensive Care Psychiatric Disorder — all drugs for Intensive Care Psychiatric Disorder →
Sponsor
Michael Rufer
Who can join
18 and older, any sex, with High Utilization / Heavy Use or Psychiatric Hospitalization. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study aims to evaluate the treatment effects as well as inhibiting and promoting factors in the implementation of the new INTUK care offer in a sample of "heavy users", i.e. psychiatric patients with 4 or more prior inpatient admissions at Klinik Zugersee, by means of a longitudinal, prospective-retrospective study. For this purpose, medical records will be analysed and participants will be asked to fill out questionnaires addressing different aspects of mental health, quality of life and patient satisfaction. In addition, semi-structured interviews will be conducted with a subset of patients as well as staff members of the INTUK care offer.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06411951
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06411951 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Michael Rufer
- Last refreshed: 16 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06411951.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing